Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Stock Option Activity (Details)

v3.20.2
Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Number of Options, Outstanding, Beginning Balance 180,912 82,627
Number of Options, Granted 472,183 100,335
Number of Options, Exercised
Number of Options, Forfeited or cancelled (42,866) (2,050)
Number of Options, Outstanding Ending Balance 610,229 180,912
Number of Options, Expected to Vest in the Future Ending Balance 337,197  
Number of Options, Exercisable 273,032  
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance 610,229  
Weighted Average Exercise Price, Outstanding Beginning Balance  
Weighted Average Exercise Price, Granted 2.61  
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price, Forfeited or cancelled 23.24  
Weighted Average Exercise Price, Outstanding 5.76
Weighted Average Exercise Price, Expected to Vest 4.17  
Weighted Average Exercise Price, Exercisable 7.72  
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest $ 5.76  
Weighted Average Remaining Contractual Life (Yrs.), Granted 4 years 8 months 23 days  
Weighted Average Remaining Contractual Life (Yrs.), Exercised 0 years  
Weighted Average Remaining Contractual Life (Yrs.), Outstanding 4 years 6 months 18 days  
Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest 4 years 7 months 24 days  
Weighted Average Remaining Contractual Life (Yrs.), Exercisable 4 years 5 months 1 day  
Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest 4 years 6 months 18 days  
Aggregate Intrinsic Value, Outstanding, Beginning Balance  
Aggregate Intrinsic Value, Granted  
Aggregate Intrinsic Value, Outstanding, Ending Balance
Aggregate Intrinsic Value, Options expected to vest in the future  
Aggregate Intrinsic Value, Options exercisable  
Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest  
2020 Stock Appreciation Rights Plan [Member]    
Number of Options, Outstanding, Beginning Balance  
Number of Options, Granted 114,179  
Number of Options, Exercised  
Number of Options, Forfeited or cancelled  
Number of Options, Outstanding Ending Balance 114,179
Number of Options, Expected to Vest in the Future Ending Balance 114,179  
Number of Options, Exercisable  
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance 114,179  
Weighted Average Exercise Price, Outstanding Beginning Balance  
Weighted Average Exercise Price, Granted 2.63  
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price, Forfeited or cancelled  
Weighted Average Exercise Price, Outstanding 2.63
Weighted Average Exercise Price, Expected to Vest 2.63  
Weighted Average Exercise Price, Exercisable  
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest $ 2.63  
Weighted Average Remaining Contractual Life (Yrs.), Outstanding Beginning 0 years  
Weighted Average Remaining Contractual Life (Yrs.), Granted 4 years 8 months 23 days  
Weighted Average Remaining Contractual Life (Yrs.), Exercised 0 years  
Weighted Average Remaining Contractual Life (Yrs.), Forfeited or cancelled 0 years  
Weighted Average Remaining Contractual Life (Yrs.), Outstanding 4 years 8 months 23 days  
Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest 4 years 8 months 23 days  
Weighted Average Remaining Contractual Life (Yrs.), Exercisable 0 years  
Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest 4 years 8 months 23 days  
Aggregate Intrinsic Value, Outstanding, Beginning Balance  
Aggregate Intrinsic Value, Granted  
Aggregate Intrinsic Value, Outstanding, Ending Balance
Aggregate Intrinsic Value, Options expected to vest in the future  
Aggregate Intrinsic Value, Options exercisable  
Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest